6662.TWO BioLASCO Taiwan Co., Ltd.

Healthcare Biotechnology Taiwan OTC Exchange
28.40 TWD
Close of Nov 6, 2026
26.56 30.74
Market cap
TWD 727M
P/E
17.9x
P/B
1.69x
ROE
7.4%
Dividend yield
5.28%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6662.TWO undervalued?

Graham number
Price28.40
Graham value24.52
Premium15.8%

6662.TWO trades 15.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BioLASCO Taiwan Co., Ltd. fundamental analysis

No fundamental analysis for BioLASCO Taiwan Co., Ltd. yet.

BioLASCO Taiwan Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BioLASCO Taiwan Co., Ltd.

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory animals in Taiwan and internationally. The company offers lab animals, such as rat, mice, and others, as well as surgical services; and rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment. It also offers reagents, including lab anim…

Full company profile